Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection.
Albers JJ, Ammon T, Gosmann D, Audehm S, Thoene S, Winter C, Secci R, Wolf A, Stelzl A, Steiger K, Ruland J, Bassermann F, Kupatt C, Anton M, Krackhardt AM.
Albers JJ, et al. Among authors: anton m.
Life Sci Alliance. 2019 Mar 15;2(2):e201900367. doi: 10.26508/lsa.201900367. Print 2019 Apr.
Life Sci Alliance. 2019.
PMID: 30877233
Free PMC article.